Nancy Lurker | President and Chief Executive Officer |
David Price | Chief Financial Officer |
François Brisebois | Laidlaw |
Andrew D'Silva | B. Riley FBR |
Yi Chen | H.C. Wainwright |
Good morning. My name is Amanda, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharma's Fiscal Period Ended December 31 2018 Financial Results Conference Call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the Company's request.